Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study
暂无分享,去创建一个
B. Alisjahbana | E. Burhan | M. Farid | S. V. van Kampen | Nugroho Susanto | S. Simon | D. Mustikawati | K. Chittenden | Shinta D. Astiti | Roni Chandra
[1] M. Mendelson,et al. False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[2] F. Cobelens,et al. Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil. , 2014, Bulletin of the World Health Organization.
[3] Grant Theron,et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial , 2014, The Lancet.
[4] John G Meara,et al. Surgery and global health: a Lancet Commission , 2014, The Lancet.
[5] Suvanand Sahu,et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries , 2014, BMC Infectious Diseases.
[6] N. Dendukuri,et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults , 2014, The Cochrane database of systematic reviews.
[7] L. Rigouts,et al. Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations , 2013, Journal of Clinical Microbiology.
[8] L. Rigouts,et al. Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard , 2013, Journal of Clinical Microbiology.
[9] L. Scott,et al. Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa , 2013, PloS one.
[10] J. Bassett,et al. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[11] W. Katagira,et al. Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda , 2012, PloS one.
[12] D. Williamson,et al. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. , 2012, Diagnostic microbiology and infectious disease.
[13] Lesley Scott,et al. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level. , 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[14] Fake Li,et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. , 2012, The Journal of infection.
[15] T. Victor,et al. False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications [Technical note]. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[16] M. Perkins,et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study , 2011 .
[17] Khatri Gr. National tuberculosis control programme. , 1996, Journal of the Indian Medical Association.
[18] T. Victor,et al. False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.